top of page


Teva Pharmaceutical Pays $519 Million to Settle Charges That It Violated the Foreign Corrupt Practices Act
By Jeffrey M. Haber On December 22, 2016, the Department of Justice (“DOJ”) announced that Teva Pharmaceutical Industries Ltd. (“Teva”), the world’s largest manufacturer of generic pharmaceutical products, and its wholly-owned Russian subsidiary, Teva LLC (“Teva Russia”), agreed to resolve criminal charges and to pay a criminal penalty of more than $283 million for violating the Foreign Corrupt Practices Act (“FCPA”). The charges relate to various schemes involving the briber

Jeffrey Haber
Jan 3, 20176 min read


Hedge Fund Giant, Och-Ziff, To Pay Over $400 Million to Settle Charges Related to Violations of the Foreign Corrupt Practices Act
On September 29, 2016, the Securities and Exchange Commission (“SEC”) and the Department of Justice (“DOJ”) announced that Och-Ziff Capital Management Group LLC (“Och-Ziff”), a New York-based alternative investment and hedge fund manager, and OZ Africa Management GP LLC (“OZ Africa”), its wholly-owned subsidiary, agreed to pay more than $400 million to settle charges that they used intermediaries and business partners to bribe officials of various African governments. The SEC

Jeffrey Haber
Oct 7, 20164 min read
bottom of page
